Silvia Daniela da Costa Teixeira
Directeur/Membre du Conseil chez Fairjourney Biologics SA
Profil
Silvia Daniela da Costa Teixeira has a current job as a Director at Fairjourney Biologics SA.
Postes actifs de Silvia Daniela da Costa Teixeira
| Sociétés | Poste | Début |
|---|---|---|
Fairjourney Biologics SA
 Fairjourney Biologics SA BiotechnologyHealth Technology Fairjourney Biologics SA is a biologics contract research organization that provides integrated services across antibody discovery, engineering, and production to biopharma. The Portuguese company operates a flexible, customer-oriented ‘ one-stop shop ’ approach to biologics development focused on quality, reliability, and partnership. Fairjourney Biologics has successfully completed more than 500 projects for over 100 customers across big pharma and leading biotech companies to date. The company's innovative mammalian display platform enables full-length antibodies to be expressed in the context of a mammalian cell, allowing selection based on function, stability, expression, and developability. The company has grown to over 130 highly technically skilled employees today and has subsidiaries in the United Kingdom. Fairjourney Biologics was founded in 2012 by António Bernadino Guimaraes Parada and Maria Gonzalez Pajuelo and is headquartered in Porto, PT. António Bernadino Guimaraes Parada has been the CEO since 2012. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Fairjourney Biologics SA
Fairjourney Biologics SA BiotechnologyHealth Technology Fairjourney Biologics SA is a biologics contract research organization that provides integrated services across antibody discovery, engineering, and production to biopharma. The Portuguese company operates a flexible, customer-oriented ‘ one-stop shop ’ approach to biologics development focused on quality, reliability, and partnership. Fairjourney Biologics has successfully completed more than 500 projects for over 100 customers across big pharma and leading biotech companies to date. The company's innovative mammalian display platform enables full-length antibodies to be expressed in the context of a mammalian cell, allowing selection based on function, stability, expression, and developability. The company has grown to over 130 highly technically skilled employees today and has subsidiaries in the United Kingdom. Fairjourney Biologics was founded in 2012 by António Bernadino Guimaraes Parada and Maria Gonzalez Pajuelo and is headquartered in Porto, PT. António Bernadino Guimaraes Parada has been the CEO since 2012. | Health Technology |
